Total flavonoids from Ampelopsis megalophylla suppress proliferation of vascular smooth muscle cells in vivo and in vitro

<div><p>ABSTRACT Various benefits of flavonoids for ameliorating cardiovascular diseases have been demonstrated. However, the lowering effects on blood pressure caused by antiproliferative potentials of flavonoids in vascular smooth muscle cells are rare. In this study, the antihypertensive effects of total flavonoids from Ampelopsis megalophylla were investigated. The dynamic pressure values and the rate of media thickness versus lumen diameter were measured by the tail-cuff system and H&E staining in vivo, respectively. The mRNA expressions of ACE, Ang II, eNOS, c-Myc, cyclin D1 and p27Kip1 in thoracic aorta or A7r5 cells were measured by qPCR, respectively. The protein expressions of c-Myc, Cyclin D1, p27Kip1 and β-catenin in tissues or A7r5 cells were measured by Western blot assay. Total flavonoids of A. megalophylla (TFAM) reduced the expressions of ACE and Ang II, and elevated the content of eNOS in thoracic aorta cells of SHRs. Furthermore, TFAM decreased the mRNA and protein expressions of c-Myc and cyclin D1 by repressing the Wnt/β-catenin-mediated TCF/LEF transcriptional activation both in vivo and in vitro, which is synergetic with the up-regulation of p27Kip1 expression. Our study provided evidence for developing flavonoids from A. megalophylla as herbal supplements to prevent against cardiovascular diseases by suppressing vascular remodeling.</p></div

Antiproliferative effect of urolithin A, the ellagic acid-derived colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting Lin28a/let-7a axis

<div><p>An abnormality in the Lin28/let-7a axis is relevant to the progression of hepatitis B virus (HBV)-positive hepatocellular carcinoma (HCC), which could be a novel therapeutic target for this malignant tumor. The present study aimed to investigate the antiproliferative and anti-invasive effects of urolithin A in a stable full-length HBV gene integrated cell line HepG2.2.15 using CCK-8 and transwell assays. The RNA and protein expressions of targets were assessed by quantitative PCR and western blot, respectively. Results revealed that urolithin A induced cytotoxicity in HepG2.2.15 cells, which was accompanied by the cleavage of caspase-3 protein and down-regulation of Bcl-2/Bax ratio. Moreover, urolithin A suppressed the protein expressions of Sp-1, Lin28a, and Zcchc11, and elevated the expression of microRNA let-7a. Importantly, urolithin A also regulated the Lin28a/let-7a axis in transient HBx-transfected HCC HepG2 cells. Furthermore, urolithin A decelerated the HepG2.2.15 cell invasion, which was involved in suppressing the let-7a downstream factors HMGA2 and K-ras. These findings indicated that urolithin A exerted the antiproliferative effect by regulating the Lin28a/let-7a axis and may be a potential supplement for HBV-infected HCC therapy.</p></div

Details of literature search and selection.

<p>Abbreviations: SCI: Science Citation Index; VIP: Chinese Sci sientific Journal Database; CNKI: China National Knowledge Information database.</p

Tai Chi versus Non-intervention: Left Ventricular Effective Pump Power.

<p>Tai Chi versus Non-intervention: Left Ventricular Effective Pump Power.</p

Tai Chi versus Non-intervention: The Forced Vital Capacity in The First Second.

<p>Tai Chi versus Non-intervention: The Forced Vital Capacity in The First Second.</p

Tai Chi versus Non-intervention: Forced Vital Capacity.

<p>Tai Chi versus Non-intervention: Forced Vital Capacity.</p

Tai Chi versus Non-intervention: Cardio Output.

<p>Tai Chi versus Non-intervention: Cardio Output.</p

Tai Chi versus Non-intervention: Myocardial Oxygen Consumption.

<p>Tai Chi versus Non-intervention: Myocardial Oxygen Consumption.</p

Tai Chi versus Non-intervention: Peak Oxygen Uptake.

<p>Tai Chi versus Non-intervention: Peak Oxygen Uptake.</p

Tai Chi versus Non-intervention: Stair Test Index.

<p>Tai Chi versus Non-intervention: Stair Test Index.</p